Homeopathic Remedy for the Third Stage of Delivery

Sponsor
Shaare Zedek Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01156194
Collaborator
(none)
210
1
3
12
17.5

Study Details

Study Description

Brief Summary

The homeopathic remedy consisting of Arnica and Bellis perennis have been shown in a previous pilot study (n=33) to reduce blood loss during the third stage of delivery, when compared with placebo treatment. The purpose of this study is to repeat the previous methodology, this time on a larger population.

210 parturients will be randomized to one of three groups: Arnica montana C6 and Bellis perennis C6 (n=70), Arnica montana C30 and Bellis perennis C30 (n=70), or double placebo (n=70).

Condition or Disease Intervention/Treatment Phase
  • Drug: Homeopathy 1
  • Drug: Homeopathy 2
  • Drug: Placebo
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
210 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of a Homeopathic Remedy on the Third Stage of Delivery: a Prospective, Randomized, Double-Blind Study.
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Jan 1, 2012
Actual Study Completion Date :
Jan 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Homeopathy 1

Arnica montana C6 and Bellis perennis C6

Drug: Homeopathy 1
Arnica montana C6 and Bellis perennis C6

Active Comparator: Homeopathy 2

Arnica montana C30 and Bellis perennis C30

Drug: Homeopathy 2
Arnica montana C30 and Bellis perennis C30

Placebo Comparator: Placebo

globules identical to true comparators

Drug: Placebo
globule identical to true homeopathy comparators

Outcome Measures

Primary Outcome Measures

  1. Hemoglobin levels at 2d postpartum [48h]

Secondary Outcome Measures

  1. incidence of endometritis [7d]

  2. time to extrusion of placenta following birth [24h]

  3. duration of lochiae secretion [7days]

  4. duration of third stage of labor [24h]

  5. assessment of quality-of-life parameters [7 days]

  6. assess toxic effects of the homeopathic remedies [7 days]

  7. serum cortisol levels [within 12h postpartum]

  8. state of perineum postpartum [48h]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy women in 3rd stage of labor

  • age 20-35

  • second to fifth gestation

  • spontaneous PV delivery

  • term delivery (37-42nd weeks)

Exclusion Criteria:
  • scarred uterus

  • multifetal pregnancy

  • history of bleeding problems

  • caesarian section delivery

  • chorioamnionitis

  • pregnancy-induced hypertension

  • gestational diabetes mellitus

  • polyhydramnios, premature rupture of membrane

  • suspected macrosomy/SGA

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maternity Ward, Shaare Zedek Medical Center Jerusalem Israel 91031

Sponsors and Collaborators

  • Shaare Zedek Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Menachem Oberbaum, Director, Center for Integrative Complementary Medicine, Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
NCT01156194
Other Study ID Numbers:
  • ArBel.2010
First Posted:
Jul 2, 2010
Last Update Posted:
Feb 22, 2012
Last Verified:
Feb 1, 2012
Keywords provided by Menachem Oberbaum, Director, Center for Integrative Complementary Medicine, Shaare Zedek Medical Center

Study Results

No Results Posted as of Feb 22, 2012